Avax One Technology Ltd. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 12, 2026, reporting quarterly operating income of $52.4 million driven by a large unrealized gain on digital assets.
NET Power Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 12, 2026, covering the fiscal quarter ended September 30, 2026.
QuoteMedia, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 12, 2026, reporting third-quarter revenue of $5,601,427 and a net loss of $157,555.
enCore Energy Corp. filed its Form 10-Q quarterly report with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, disclosing a share count of 195,668,102 common shares outstanding as of November 9, 2026.
SES AI Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 12, 2026, covering the fiscal quarter ended September 30, 2026.
Spero Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 12, 2026, disclosing a strategic shift toward SP001 development following the FDA's June 2026 approval of Utebzi.
Cibus, Inc. filed its quarterly report on Form 10-Q with the Securities and Exchange Commission on November 12, 2026, covering the fiscal quarter ended September 30, 2026, and reporting 76,640,011 shares of Class A Common Stock outstanding as of November 6, 2026.
Colombier Acquisition Corp. III filed a Form 10-Q with the SEC on November 12, 2026, covering the quarterly period ended September 30, 2026, disclosing its financial condition and operational status as a blank-check special purpose acquisition company listed on the New York Stock Exchange.
Pono Capital Four, Inc. filed a Form 10-Q with the SEC on November 12, 2026, covering the quarterly period ended September 30, 2026, its first such report since the company's inception on January 2, 2026.
AIM ImmunoTech Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with NYSE American on November 12, 2026, reporting a net loss of $3.143 million for the third quarter and a significant increase in shares outstanding driven by stock issuances, …